ACC/AHA/SCAI/SIR/SVM 2018 Appropriate Use Criteria for Peripheral Artery Intervention: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Heart Association, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, and So
暂无分享,去创建一个
L. Wann | J. Halperin | J. Beckman | S. Parikh | S. Bailey | E. Yucel | M. Jaff | A. Reed | A. Hirsch | C. White | H. Aronow | R. Fazel | P. Sobieszczyk | F. Shamoun | H. Gornik | S. Misra | V. Krishnamurthy | B. Gray | Rita Shugart | Timothy Dao | Piotr S. Sobieszczyk | C. White | Rita E Shugart
[1] Jackson T. Wright,et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Journal of the American College of Cardiology.
[2] B. Lindsay,et al. ACC Appropriate Use Criteria Methodology: 2018 Update: A Report of the American College of Cardiology Appropriate Use Criteria Task Force. , 2018, Journal of the American College of Cardiology.
[3] Laura G. Qualls,et al. The Effect of Clinical Care Location on Clinical Outcomes After Peripheral Vascular Intervention in Medicare Beneficiaries. , 2017, JACC. Cardiovascular interventions.
[4] J. Cigarroa,et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease , 2016, Circulation.
[5] W. H. Hoffmann,et al. Endovascular Revascularization and Supervised Exercise for Peripheral Artery Disease and Intermittent Claudication: A Randomized Clinical Trial. , 2015, JAMA.
[6] D. Scheinert,et al. Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. , 2015, The New England journal of medicine.
[7] M. Mack,et al. Propensity-Matched Comparisons of Clinical Outcomes After Transapical or Transfemoral Transcatheter Aortic Valve Replacement: A Placement of Aortic Transcatheter Valves (PARTNER)-I Trial Substudy , 2015, Circulation.
[8] J. Massaro,et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. , 2015, Journal of the American College of Cardiology.
[9] Fares Alahdab,et al. A systematic review of treatment of intermittent claudication in the lower extremities. , 2015, Journal of vascular surgery.
[10] O. Iida,et al. Two-year life expectancy in patients with critical limb ischemia. , 2014, JACC. Cardiovascular interventions.
[11] O. Jazaeri,et al. Overview of Classification Systems in Peripheral Artery Disease , 2014, Seminars in Interventional Radiology.
[12] Ralph B D'Agostino,et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. , 2014, The New England journal of medicine.
[13] Jackson T. Wright,et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). , 2014, JAMA.
[14] T. Mackenzie,et al. Growing Impact of Restenosis on the Surgical Treatment of Peripheral Arterial Disease , 2013, Journal of the American Heart Association.
[15] P. Sobieszczyk,et al. Management of Patients After Endovascular Interventions for Peripheral Artery Disease , 2013, Circulation.
[16] J. Teijink,et al. Endovascular revascularisation versus conservative management for intermittent claudication. , 2013, The Cochrane database of systematic reviews.
[17] Richard D. White,et al. 2013 appropriate utilization of cardiovascular imaging: a methodology for the development of joint criteria for the appropriate utilization of cardiovascular imaging by the American College of Cardiology Foundation and American College of Radiology. , 2013, Journal of the American College of Cardiology.
[18] Christopher M Kramer,et al. Multimodality Imaging of Lower Extremity Peripheral Arterial Disease: Current Role and Future Directions , 2012, Circulation. Cardiovascular imaging.
[19] M. Nobuyoshi,et al. Classification and clinical impact of restenosis after femoropopliteal stenting. , 2012, Journal of the American College of Cardiology.
[20] J. Ehrman,et al. Supervised Exercise Versus Primary Stenting for Claudication Resulting From Aortoiliac Peripheral Artery Disease: Six-Month Outcomes From the Claudication Exercise Versus Endoluminal Revascularization (CLEVER) Study , 2012, Circulation.
[21] N. Weissman,et al. Excimer Laser Recanalization of Femoropopliteal Lesions and 1-Year Patency: Results of the CELLO Registry , 2009, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.
[22] D. Scheinert,et al. Nitinol Stent Implantation Versus Percutaneous Transluminal Angioplasty in Superficial Femoral Artery Lesions up to 10 cm in Length: The Femoral Artery Stenting Trial (FAST) , 2007, Circulation.
[23] Jason A. Mitchell,et al. Predicting blood pressure improvement in hypertensive patients after renal artery stent placement , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[24] Johannes Lammer,et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. , 2006, The New England journal of medicine.
[25] Rodney A. White,et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Ang , 2006, Journal of the American College of Cardiology.
[26] K. Verhamme,et al. Assessment of renal flow and flow reserve in humans. , 2006, Journal of the American College of Cardiology.
[27] R. Hendel,et al. ACCF proposed method for evaluating the appropriateness of cardiovascular imaging. , 2005, Journal of the American College of Cardiology.
[28] K. Rosenfield,et al. Renal fractional flow reserve: A hemodynamic evaluation of moderate renal artery stenoses , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[29] F. Moll,et al. Patient selection and perioperative outcomes of bypass and endovascular intervention as first revascularization strategy for infrainguinal arterial disease , 2018, Journal of vascular surgery.
[30] L. Fleisher,et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Journal of the American College of Cardiology.
[31] Carlos Mena-Hurtado,et al. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis). , 2015, JACC. Cardiovascular interventions.
[32] John V. White,et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.